Adam Pascale
2018
In 2018, Adam Pascale earned a total compensation of $392.5K as CFO at Hemispherx Biopharma, a 33% increase compared to previous year.
Compensation breakdown
| Option Awards | $99,979 |
|---|---|
| Salary | $251,000 |
| Stock Awards | $500 |
| Other | $40,973 |
| Total | $392,452 |
Pascale received $251K in salary, accounting for 64% of the total pay in 2018.
Pascale also received $100K in option awards, $500 in stock awards and $41K in other compensation.
Rankings
In 2018, Adam Pascale's compensation ranked 12,590th out of 14,244 executives tracked by ExecPay. In other words, Pascale earned more than 11.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,590 out of 14,244 | 12th |
Division Manufacturing | 5,099 out of 5,759 | 12th |
Major group Chemicals And Allied Products | 1,930 out of 2,122 | 9th |
Industry group Drugs | 1,654 out of 1,811 | 9th |
Industry Biological Products, Except Diagnostic Substances | 320 out of 339 | 6th |
Source: SEC filing on August 20, 2019.
Pascale's colleagues
We found two more compensation records of executives who worked with Adam Pascale at Hemispherx Biopharma in 2018.